로딩 중…
지수 로딩 중…
argenx SE
ARGX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
NL
$877.72-1.63%
2026-06-18
Price Chart
argenx SE+63.17%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $54.85B |
| Revenue | $6.30B |
| Net Income | $2.33B |
| Total Assets | $8.68B |
| Net Assets | $7.32B |
| Value | |
| P/E | 23.56x |
| P/B | 7.49x |
| PEG | 0.03x |
| P/S | 8.71x |
| EV/EBITDA | 38.72x |
| Profitability | |
| ROE | 31.79% |
| ROA | 26.81% |
| Op. Margin | 19.52% |
| Revenue Growth | 319.79% |
| Earnings Growth | 857.14% |
| Financial Health | |
| Debt Ratio | 18.57% |
| Total Debt | $83M |
| Cash | $3.49B |
| Current Ratio | 5.23x |
| Net Debt/EBITDA | -2.57x |
| Performance | |
| 1Y Return | 63.17% |
| 1M Return | 10.02% |
| From 52W High | -6.09% |
| 1Y MDD | -28.58% |
| Trading | |
| Volume | 350,196 shares |
| Trading Value | $309M |
| Per Share | |
| EPS | $35.09 |
| BPS | $119.23 |